NCT03742258 2025-06-18Combination Chemotherapy and TAK-659 as Front-Line Treatment in Treating Patients With High-Risk Diffuse Large B Cell LymphomaNorthwestern UniversityPhase 1 Completed12 enrolled 13 charts
NCT03756818 2023-02-28TAK-659 and Paclitaxel in Treating Patients With Advanced Solid TumorsM.D. Anderson Cancer CenterPhase 1 Completed52 enrolled